Vertex Pharmaceuticals · 20 hours ago
Director, Market Access Strategy – AMKD (inaxaplin)
Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. The Director, Market Access Strategy Lead – AMKD (inaxaplin) is responsible for leading the development of Market Access strategies and execution of access resources for the commercialization of inaxaplin, requiring collaboration across multiple functions and the creation of impactful market access resources.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Provide critical leadership in developing brand and market access strategies by payer channel, to support patient access for inaxaplin via the creation and delivery of impactful market access resources
Refinement and execution of the go to market access strategy to compete in a dynamic external landscape
Lead initiatives to understand, analyze and demonstrate the clinical, economic, and societal value to payers, decision-makers, and influencers based on FDAMA114 guidelines (aka Pre-approval Information Exchanges)
Develop, train, and implement the necessary promotional resources and reimbursement pull-through that support field account teams’ efforts with key customers
Chair the inaxaplin LRT process across the cross-functional business partners
Collaborate with Internal stakeholders to plan and implement Market Research
Customize strategies based on Commercial, Medicaid & Medicare demographics, legislation, & trends
Identify and address key product barriers to payer access and performance by applying advanced payer analytics and market trends
Oversee agency and external vendors to deliver resources and strategic insights on time and within budget
Accountable for LRM materials and training of Field team
Developing KPIs and metrics to assess impact of key initiatives
Act as trusted, subject matter expert on US payer landscape to internal colleagues and externally customers
Qualification
Required
Expert knowledge of US healthcare system, including gov't & commercial payers, policy, and regulatory environment
Previous contract strategy leadership experience in the pharmaceutical/biotech or healthcare industry
Experience in developing and articulating a clear and pragmatic value proposition
Proven track record of meeting or exceeding objectives & goals, both as an individual and as part of a team
Excellent communication skills with experience presenting to customers and internal leadership
Demonstrated ability to successfully lead cross-functional teams, influencing without direct authority, with the interpersonal skills to foster collaboration and succeed in a highly matrixed environment
Ability to perform in a fast-paced environment, manage multiple priorities simultaneously, and work effectively across cross-functional teams
Bachelor's degree
Typically requires 8+ years of MA experience or the equivalent combination of education and experience
Preferred
Preference for candidate with prior, directly relevant product experience (i.e., kidney diseases, genetic diseases, companion diagnostics) and launch experience
Benefits
Inclusive market-leading benefits to meet our employees wherever they are in their career, financial, family and wellbeing journey while providing flexibility and resources to support their growth and aspirations.
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Recent News
2026-01-23
Benzinga.com
2026-01-23
2026-01-22
Company data provided by crunchbase